Ajooni Biotech Limited - Laporan Laba Rugi (TTM)

Ajooni Biotech Limited
IN ˙ NSEI
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Ajooni Biotech Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 455 466 510 571 633 697 740 705 624 537 745 832 924 1,018 803 848 912 1,051 1,147 1,203
Change (%) 2.47 9.44 11.78 11.01 10.07 6.20 -4.78 -11.49 -13.87 38.60 11.67 11.05 10.20 -21.16 5.63 7.53 15.34 9.09 4.89
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 390 397 430 483 534 597 640 609 537 450 657 743 836 933 703 740 790 898 970 1,002
Change (%) 1.65 8.37 12.26 10.49 11.81 7.31 -4.87 -11.89 -16.17 46.14 12.99 12.61 11.59 -24.63 5.17 6.72 13.75 8.03 3.23
% of Revenue 85.79 85.11 84.27 84.64 84.24 85.57 86.46 86.38 85.99 83.70 88.26 89.30 90.56 91.70 87.66 87.28 86.61 85.42 84.60 83.26
Gross Operating Profit 65 69 80 88 100 101 100 96 87 88 87 89 87 84 99 108 122 153 177 201
Change (%) 7.39 15.59 9.21 13.86 0.80 -0.35 -4.19 -8.98 0.19 -0.15 1.76 -2.01 -3.15 17.27 8.91 13.12 25.61 15.26 14.04
% of Revenue 14.21 14.89 15.73 15.36 15.76 14.43 13.54 13.62 14.01 16.30 11.74 10.70 9.44 8.30 12.34 12.72 13.39 14.58 15.40 16.74
SG&A 32 22 52 12 54 55 56 16 58 59 51 18 52 53 64 18 67 69 28 32
Change (%) -30.21 131.63 -76.69 349.04 1.75 1.48 -71.00 255.99 1.15 -13.04 -65.16 190.56 1.93 22.47 -71.43 262.48 4.16 -60.25 15.21
% of Revenue 7.04 4.80 10.15 2.12 8.57 7.92 7.57 2.30 9.27 10.89 6.83 2.13 5.58 5.16 8.01 2.17 7.30 6.60 2.40 2.64
R&D
Change (%)
% of Revenue
OpEx 441 455 499 559 618 677 719 685 608 525 725 815 904 1,009 784 831 889 1,013 1,121 1,180
Change (%) 3.05 9.86 11.99 10.41 9.63 6.16 -4.68 -11.33 -13.58 38.09 12.36 10.91 11.62 -22.31 6.08 6.89 13.99 10.67 5.25
% of Revenue 96.94 97.49 97.87 98.05 97.52 97.13 97.09 97.19 97.37 97.71 97.35 97.95 97.83 99.09 97.64 98.06 97.48 96.34 97.74 98.07
Operating Income 14 12 11 11 16 20 22 20 16 12 20 17 20 9 19 16 23 38 26 23
Change (%) -16.00 -6.94 2.13 41.34 27.30 7.63 -8.08 -17.10 -24.93 60.04 -13.56 17.77 -53.87 104.49 -13.23 39.89 67.40 -32.58 -10.53
% of Revenue 3.06 2.51 2.13 1.95 2.48 2.87 2.91 2.81 2.63 2.29 2.65 2.05 2.17 0.91 2.36 1.94 2.52 3.66 2.26 1.93
Interest Expense -1 -3 -6 -1 -0 -5 -5 -1 -1 -6 -3 -3
Change (%) 351.27 -76.04 -99.11 -81.93 -4.75 -19.62
% of Revenue -0.16 -0.71 -1.07 -0.23 -0.00 -0.72 -0.62 -0.10 -0.09 -0.68 -0.29 -0.22
Net Income 7 4 4 4 7 11 10 11 9 5 11 12 15 18 22 22 26 27 34 37
Change (%) -37.50 -8.82 3.12 69.11 63.59 -1.45 0.81 -18.64 -37.05 107.69 7.10 20.71 22.82 21.03 3.07 18.24 4.15 22.93 9.29
% of Revenue 1.44 0.88 0.73 0.67 1.03 1.53 1.42 1.50 1.38 1.01 1.51 1.45 1.57 1.75 2.69 2.63 2.89 2.61 2.94 3.06

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista